Literature DB >> 16763090

Functional mapping of the transient receptor potential vanilloid 1 intracellular binding site.

Daniel M Johnson1, Elizabeth M Garrett, Richard Rutter, Timothy P Bonnert, Ying-Duo Gao, Richard E Middleton, Kathy G Sutton.   

Abstract

Capsaicin (vanilloid) sensitivity has long served as the functional signature of a subset of nociceptive sensory neurons. Mutagenesis studies have revealed seemingly distinct regions involved in mediating ligand binding and channel activation at the capsaicin binding site. Residue 547 (transmembrane region 4) mediates significant species differences in resiniferatoxin (RTX) sensitivity, and the Ser(512) residue is critical in discriminating between pH and capsaicin gating. In the present study, the pharmacological profiles of a variety of ligands were studied to investigate cross-talk between these two regions. Exchange of residue 547 between species mediated a difference in capsaicin and RTX-dependent gating. Likewise, the potency of iodoresiniferatoxin (I-RTX) and a novel transient receptor potential vanilloid 1 antagonist were also altered. Experiments using the S512Y mutant channel have confirmed the importance of residue 512 for functional interaction of capsaicin and our novel antagonist. In this study, we were surprised to find that the mutation S512Y converted the activity of the antagonist I-RTX into an intrinsic agonist, albeit with a lower potency than its parent compound, RTX. Recent studies have proposed a novel model for the receptor, based on the X-ray crystal structure of the voltage-dependent potassium channel, in which both the 512 and 547 amino acid residues are in close proximity. Our data support the model whereby intracellular ligand interaction occurs within an S3-S4 "sensor" domain, enabling binding of ligands to be transduced to functional gating of the channel. The binding pocket also seems to be exquisitely sensitive to residue-specific interaction with ligands, because subtle changes in either ligand or channel structure can have profound effects on channel activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16763090     DOI: 10.1124/mol.106.023945

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  13 in total

1.  Targeting the voltage sensor of Kv7.2 voltage-gated K+ channels with a new gating-modifier.

Authors:  Asher Peretz; Liat Pell; Yana Gofman; Yoni Haitin; Liora Shamgar; Eti Patrich; Polina Kornilov; Orit Gourgy-Hacohen; Nir Ben-Tal; Bernard Attali
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

Review 2.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.

Authors:  R G Pertwee; A C Howlett; M E Abood; S P H Alexander; V Di Marzo; M R Elphick; P J Greasley; H S Hansen; G Kunos; K Mackie; R Mechoulam; R A Ross
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 3.  Neurobiological applications of small molecule screening.

Authors:  Andras Bauer; Brent Stockwell
Journal:  Chem Rev       Date:  2008-05-01       Impact factor: 60.622

Review 4.  ThermoTRPs and Pain.

Authors:  Robyn J Laing; Ajay Dhaka
Journal:  Neuroscientist       Date:  2015-01-21       Impact factor: 7.519

5.  Distinct modulations of human capsaicin receptor by protons and magnesium through different domains.

Authors:  Shu Wang; Kinning Poon; Robert E Oswald; Huai-hu Chuang
Journal:  J Biol Chem       Date:  2010-02-09       Impact factor: 5.157

Review 6.  Breathtaking TRP channels: TRPA1 and TRPV1 in airway chemosensation and reflex control.

Authors:  Bret F Bessac; Sven-Eric Jordt
Journal:  Physiology (Bethesda)       Date:  2008-12

7.  Molecular modeling of the full-length human TRPV1 channel in closed and desensitized states.

Authors:  G Fernández-Ballester; A Ferrer-Montiel
Journal:  J Membr Biol       Date:  2008-09-14       Impact factor: 1.843

Review 8.  The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor.

Authors:  P Holzer
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

9.  Drug-induced mild therapeutic hypothermia obtained by administration of a transient receptor potential vanilloid type 1 agonist.

Authors:  Keld Fosgerau; Uno J Weber; Jacob W Gotfredsen; Magdalena Jayatissa; Carsten Buus; Niels B Kristensen; Mogens Vestergaard; Peter Teschendorf; Andreas Schneider; Philip Hansen; Jakob Raunsø; Lars Køber; Christian Torp-Pedersen; Charlotte Videbaek
Journal:  BMC Cardiovasc Disord       Date:  2010-10-09       Impact factor: 2.298

Review 10.  Functionally important amino acid residues in the transient receptor potential vanilloid 1 (TRPV1) ion channel--an overview of the current mutational data.

Authors:  Zoltán Winter; Andrea Buhala; Ferenc Ötvös; Katalin Jósvay; Csaba Vizler; György Dombi; Gerda Szakonyi; Zoltán Oláh
Journal:  Mol Pain       Date:  2013-06-22       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.